• SENSEX 74,258.51
    -523.25 (--0.70%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • HDFC Bank
    730.30 1,020.35(%)
  • Solar Industries
    19,273.75 11,641.10(%)
  • Raymond
    1,121.80 1,024.00(%)
  • Zensar Tech.
    479.80 868.50(%)
  • Infosys
    1,097.40 1,727.85(%)
  • Tata Inv.Corpn.
    750.30 1,184.00(%)
  • ESDS Software
    1,802.15 1,716.35(%)
  • Reliance Industries
    1,248.50 1,250.55(%)
  • TCS
    2,322.50 3,336.70(%)
  • Pine Labs
    191.50 134.75(%)
  • Hero Motocorp
    5,325.55 6,390.00(%)
  • Gland Pharma
    2,867.95 1,575.00(%)
  • Netweb Technol.
    4,654.00 2,820.80(%)
  • SBI
    977.40 816.25(%)
  • JSW Holdings
    10,990.00 10,500.05(%)
  • Bharat Electron
    387.65 380.35(%)
  • Cummins India
    4,930.00 3,802.55(%)
  • Coforge
    1,776.00 1,008.50(%)
  • HCL Technologies
    1,290.10 1,770.00(%)
  • Afcons Infrastr.
    304.70 479.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Pharmaids Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3844.0
  • ISIN : INE117D01018
30.31 0 (0.73%)
  • As on 15 Sep 2026 (EOD)

  • Today’s Low

    29.52

  • Today’s High

    31.29

  • Open

    31.29

  • Perv Close

    30.09

  • 52W Low

    25.60

  • 52W High

    66.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    106.90

  • Div & Yield %

    0.00

  • Book Value(₹)

    15.14

  • Debt-Equity Ratio

    0.73

  • AGM Date

    11-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    106.90

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    35.27

  • BV (₹)

    15.10

  • Sales( ₹ in Cr.)

    10.60

  • NP (in Cr.)

    -13.55

  • NP Var(%)

    -86.0

  • Div%

    0.0

  • CPS (₹)

    -3.80

  • EPS (₹)

    -3.80

  • Traded Value (₹ in Lakhs)

    106.90

  • 52 Week High

    66.00

  • 52 Week Low

    25.60

  • Price BSE

    30.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    106.90

  • P/C Ratio

    -7.90

  • P/E Ratio

    -7.80

  • Price Vs.BV

    -3.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 10.60 2.34 0.03 0.00 3.94 8.55
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 10.60 2.34 0.03 0.00 3.94 8.55
Other Income 3.81 1.02 0.80 0.00 0.02 0.03
Stock Adjustments -0.12 -0.11 0.23 -0.89 0.52 0.37
Total Income 14.29 3.25 1.06 -0.89 4.48 8.95
EXPENDITURE :            
Raw Materials 11.31 1.90 0.25 0.00 4.09 8.53
Power and Fuel Cost 0.27 0.05 0.01 0.00 0.00 0.00
Employee Cost 5.40 3.42 1.99 1.13 0.04 0.04
Other Manufacturing Expenses 0.15 0.02 0.04 0.02 0.00 0.00
Selling and Administration Expenses 6.96 1.69 1.45 0.80 0.19 0.23
Miscellaneous Expenses 0.65 2.41 2.88 7.06 0.00 0.01
Employee Benefit Expenses 5.40 3.42 1.99 1.13 0.04 0.04
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 24.74 9.49 6.62 9.00 4.32 8.82
Operating Profit -10.43 -6.24 -5.58 -9.89 0.15 0.13
Interest 3.31 2.15 0.33 0.00 0.00 0.00
Gross Profit -13.74 -8.39 -5.91 -9.89 0.15 0.13
Depreciation 0.21 0.20 0.18 0.02 0.01 0.04
Profit Before Tax -13.95 -8.59 -6.09 -9.91 0.14 0.09
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -3.52 -1.31 -1.14 -2.35 0.00 0.00
Reported Net Profit -10.44 -7.28 -4.95 -7.56 0.15 0.09
Extraordinary Items 3.11 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -13.55 -7.28 -4.95 -7.56 0.15 0.09
Adjustment below Net Profit 0.00 0.00 -0.04 0.00 0.00 0.00
P & L Balance brought forward -22.16 -14.88 -9.89 -2.33 -2.48 -2.57
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -32.60 -22.16 -14.88 -9.89 -2.33 -2.48
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -2.96 -2.06 -1.40 -3.52 0.14 0.09
Earnings Per Share(Adj)-Unit Curr -2.96 -2.06 -1.40 -3.52 0.14 0.09
Book Value 15.14 18.09 20.15 10.46 8.44 8.30
Book Value(Adj)-Unit Curr 15.14 18.09 20.15 10.46 8.44 8.30

Shareholding Pattern

  • Promoter Group

    32.99%

  • Public Share Holding

    67.01%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,568,000 4.45 1,568,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 10,066,519 28.54 10,066,519 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 11,634,519 32.99 11,634,519 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 122,352 0.35 121,352 23
Clearing Members 0 0.00 0 0
Directors of their Relatives 5,942,902 16.85 5,942,902 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 335,762 0.95 335,762 46
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 138,186 0.39 138,186 65
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 13,153,974 37.30 13,062,044 76
Individuals holding nominal share capital up to Rs. 1 lakh 3,631,167 10.30 2,756,366 8,408
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 205,409 0.58 205,409 2
Sub Total 23,633,293 67.01 22,665,562 8,628
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 35,267,812 100.00 34,300,081 8,632

Company Background

Pharmaids Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Pharmaids Pharmaceuticals Ltd
  • BSE Code : 3844.0
  • ISIN : INE117D01018

  • Incorporation Year

    1989

  • Registered Office

    4-4-211/212/3 1st Floor
    Inderbagh Sulthan Bazar, Hyderabad,
    Telangana-500095

  • Telephone

    91-40-66669809

  • FAX

    91-40-23232348

  • Chairman

    Shankarappa Nagaraja Vinaya Babu

  • Managing Director

  • Company Secretary

    Prasanna Subramanya Bhat

  • Auditor

    PPKG & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Pharmaids Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Pharmaids Pharma 30.31 11.26 10.60 -27.06 0.00
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77